Optometrist · North Bergen, NJ
NPI
1437198009
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7922 Kennedy Blvd, Optometric Physician
North Bergen, NJ, 07047
Phone (201) 295-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
1,434 services
Medicare patients, 2024
201
Average age 78
Drug cost, 2024
$3.0M
3,861 prescriptions
Company payments, 2025
$100K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rodolfo L Rodriguez was code 99213 (office e&m - established), 377 times for 171 patients. In total Rodolfo L Rodriguez billed 1,434 services in 17 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 377 | 171 | $63.24 | $24K |
| 92083 Vision, Hearing, and Speech Services | Office | 171 | 137 | $53.92 | $9,220 |
| 92133 Computerized Ophthalmic Imaging | Office | 150 | 128 | $31.30 | $4,694 |
| 92020 Ophthalmological E&M | Office | 142 | 137 | $24.65 | $3,500 |
| 92250 Angiography | Office | 136 | 136 | $30.99 | $4,214 |
| 92014 Ophthalmological E&M | Office | 134 | 134 | $103.85 | $14K |
| 76514 Ultrasound - Nonspecific | Office | 94 | 93 | $9.39 | $883 |
| 92286 Standard X-ray | Office | 83 | 82 | $34.95 | $2,901 |
| 92134 Computerized Ophthalmic Imaging | Office | 55 | 53 | $33.24 | $1,828 |
| 92285 Standard X-ray | Office | 48 | 48 | $19.21 | $922 |
| 92004 Ophthalmological E&M | Office | 16 | 16 | $123.90 | $1,982 |
| 99214 Office E&M - Established | Office | 14 | 13 | $96.79 | $1,355 |
By year: 2022 $82K for 1,762 services; 2023 $82K for 1,745 services; 2024 $70K for 1,434 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rodolfo L Rodriguez prescribed most often to Medicare patients was Cequa (Cyclosporine), with 895 prescriptions and refills. In total Rodolfo L Rodriguez wrote 3,861 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cequa Cyclosporine | 895 | 1,509 | 264 | $850K |
| Restasis Cyclosporine | 426 | 816 | 152 | $502K |
| Lumigan Bimatoprost | 324 | 650 | 91 | $174K |
| Miebo Perfluorohexyloctane/Pf | 309 | 412 | 102 | $329K |
| Latanoprost Generic | 280 | 588 | 91 | $3,750 |
| Xiidra Lifitegrast | 257 | 471 | 100 | $320K |
| Xdemvy Lotilaner | 231 | 334 | 226 | $433K |
| Timolol Maleate Generic | 101 | 190 | 32 | $1,319 |
| Vyzulta Latanoprostene Bunod | 96 | 202 | 36 | $59K |
| Alphagan P Brimonidine Tartrate | 80 | 103 | 12 | $20K |
| Tyrvaya Varenicline Tartrate | 75 | 123 | 23 | $79K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 71 | 71 | 62 | $2,633 |
| Brinzolamide Generic | 52 | 101 | 18 | $8,645 |
| Vevye Cyclosporine | 52 | 92 | 18 | $40K |
| Tafluprost Tafluprost/Pf | 44 | 129 | 21 | $12K |
Brand drugs: 3,175 claims; generic drugs: 686 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rodolfo L Rodriguez $100K ($100K in general payments such as food, travel and fees) from 11 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $38K.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 46 | $38K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 45 | $28K |
| Alcon Vision LLC ALC | 34 | $17K |
| Bausch & Lomb Americas Inc. BLCO | 26 | $16K |
| Abbvie Inc. ABBV | 8 | $546 |
| Oyster Point Pharma, Inc. | 4 | $86.46 |
| CooperVision Inc. COO | 1 | $53.59 |
| Biotissue Holdings Inc. | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $19.73 |
| Harrow Eye, LLC | 1 | $16.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.